Submitted: 17 July 2008 Accepted: 8 October 2008 REFERENCES 1. Artavanis-Tsakonas, S., M.D. Rand, and R.J. Lake. 1999. Notch Signaling: Cell fate control and signal integration in development. Science. 284:770–776. 2. O’Neil, J., J. Grim, P. Strack, S. Rao, D. Tibbitts, C. Winter, J. Hardwick, M. Welcker, J.P. Meijerink, R. Pieters, et al. 2007. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J. Exp. Med. 204:1813–1824. 3. Thompson, B.J., S. Buonamici, M.L. Sulis, T. Palomero, T. Vilimas, G. Basso, A. Ferrando, and I. Aifantis. 2007. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J. Exp. Med. 204:1825–1835. 4. Weng, A.P., A.A. Ferrando, W. Lee, J.P.T. Morris, L.B. Silverman, C. Sanchez-Irizarry, S.C. Blacklow, A.T. Look, and J.C. Aster. 2004. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 306:269–271. 5. Palomero, T., W.K. Lim, D.T. Odom, M.L. Sulis, P.J. Real, A. Margolin, K.C. Barnes, J. O’Neil, D. Neuberg, A.P. Weng, et al. 2006. NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc. Natl. Acad. Sci. USA. 103:18261–18266. 6. Weng, A.P., J.M. Millholland, Y. Yashiro-Ohtani, M.L. Arcangeli, A. Lau, C. Wai, C. del Bianco, C.G. Rodriguez, H. Sai, J. Tobias, et al. 2006. c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia/lymphoma. Genes Dev. 20:2096–2109. 7. Felsher, D.W., and J.M. Bishop. 1999. Reversible tumorigenesis by MYC in hematopoietic lineages. Mol. Cell. 4:199–207. 8. Girard, L., Z. Hanna, N. Beaulieu, C.D. Hoemann, C. Simard, C.A. Kozak, and P. Jolicoeur. 1996. Frequent provirus insertional mutagenesis of Notch1 in thymomas of MMTVD/myc transgenic mice suggests a collab- oration of c-myc and Notch1 for oncogenesis. Genes Dev. 10:1930–1944. 9. Ikawa, T., H. Kawamoto, A.W. Goldrath, and C. Murre. 2006. E pro- teins and Notch signaling cooperate to promote T cell lineage specifica- tion and commitment. J. Exp. Med. 203:1329–1342. 10. Pear, W.S., and J.C. Aster. 2004. T cell acute lymphoblastic leuke- mia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr. Opin. Hematol. 11:426–433. 11. Raulet,D.H.,R.D.Garman,H.Saito,andS.Tonegawa.1985.Developmental regulation of T-cell receptor gene expression. Nature. 314:103–107. 12. Snodgrass, H.R., Z. Dembic, M. Steinmetz, and H. von Boehmer. 1985. Expression of T-cell antigen receptor genes during fetal develop- ment in the thymus. Nature. 315:232–233. 13. Huesmann, M., B. Scott, P. Kisielow, and H. von Boehmer. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell. 66:533–540. 14. Fehling, H.J., A. Krotkova, C. Saint-Ruf, and H. von Boehmer. 1995. Crucial Role of the pre-T-cell receptor alpha gene in development of alpha beta but not gamma delta T cells. Nature. 375:795–798. 15. Matthias, P., and A.G. Rolink. 2005. Transcriptional networks in de- veloping and mature B cells. Nat. Rev. Immunol. 5:497–508. 16. Bain, G., I. Engel, E.C. Robanus Maandag, H.P. te Riele, J.R. Voland, L.L. Sharp, J. Chun, B. Huey, D. Pinkel, and C. Murre. 1997. E2A defi- ciency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:4782–4791. 17. Engel, I., and C. Murre. 2002. Disruption of pre-TCR expression ac- celerates lymphomagenesis in E2A-deficient mice. Proc. Natl. Acad. Sci. USA. 99:11322–11327. 18. Talora, C., A.F. Campese, D. Bellavia, M. Pascucci, S. Checquolo, M. Groppioni, L. Frati, H. von Boehmer, A. Gulino, and I. Screpanti. 2003. Pre-TCR triggered ERK signaling-dependent downregulation of E2A activity in Notch3-induced T-cell lymphoma. EMBO Rep. 4:1067–1072. 19. Nie, L., M. Xu, A. Vladimirova, and X.H. Sun. 2003. Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase ac- tivities. EMBO J. 22:5780–5792. 20. Sicinska, E., I. Aifantis, L. Le Cam, W. Swat, C. Borowski, Q. Yu, A.A. Ferrando, S.D. Levin, Y. Geng, H. von Boehmer, and P. Sicinski. 2003. Requirement for cyclin D3 in lymphocyte development and T-cell leu- kemias. Cancer Cell. 4:451–461. JEM VOL. 205, November 24, 2008 A RT I C L E 21. Raval, A., S.M. Tanner, J.C. Byrd, E.B. Angerman, J.D. Perko, S.S. Chen, B. Hackanson, M.R. Grever, D.M. Lucas, J.J. Matkovic, et al. 2007. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell. 129:879–890. 22. Menssen, A., and H. Hermeking. 2002. Characterization of the c- MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc. Natl. Acad. Sci. USA. 99:6274–6279. 23. de Alboran, I.M., R.C. O’Hagan, F. Gartner, B. Malynn, L. Davidson, R. Rickert, K. Rajewsky, R.A. DePinho, and F.W. Alt. 2001. Analysis of C-MYC function in normal cells via conditional gene-targeted muta- tion. Immunity. 14:45–55. 24. Wolfer, A., T. Bakker, A. Wilson, M. Nicolas, V. Ioannidis, D.R. Littman, P.P. Lee, C.B. Wilson, W. Held, H.R. MacDonald, and F. Radtke. 2001. Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat. Immunol. 2:235–241. 25. Weng, A.P.,Y. Nam, M.S.Wolfe,W.S. Pear, J.D. Griffin, S.C. Blacklow, and J.C.Aster. 2003. Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling. Mol. Cell. Biol. 23:655–664. 26. Adhikary, S., and M. Eilers. 2005. Transcriptional regulation and trans- formation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6:635–645. 27. Bahram, F., N. von der Lehr, C. Cetinkaya, and L.G. Larsson. 2000. c- Myc hot spot mutations in lymphomas result in inefficient ubiquitination and decreased proteasome-mediated turnover. Blood. 95:2104–2110. 28. Eischen, C.M., J.D. Weber, M.F. Roussel, C.J. Sherr, and J.L. Cleveland. 1999. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev. 13:2658–2669. 29. Jacobs, J.J., B. Scheijen, J.W. Voncken, K. Kieboom, A. Berns, and M. van Lohuizen.1999.Bmi-1 collaborates with c-Myc in tumorigenesis by inhibit- ing c-Myc-induced apoptosis via INK4a/ARF. Genes Dev. 13:2678–2690. 30. Maser, R.S., B. Choudhury, P.J. Campbell, B. Feng, K.K. Wong, A. Protopopov, J. O’Neil, A. Gutierrez, E. Ivanova, I. Perna, et al. 2007. Chromosomally unstable mouse tumours have genomic alterations sim- ilar to diverse human cancers. Nature. 447:966–971. 31. Karlsson, A., S. Giuriato, F. Tang, J. Fung-Weier, G. Levan, and D.W. Felsher. 2003. Genomically complex lymphomas undergo sustained tu- mor regression upon MYC inactivation unless they acquire novel chro- mosomal translocations. Blood. 101:2797–2803. 32. Ferrando, A.A., D.S. Neuberg, J. Staunton, M.L. Loh, C. Huard, S.C. Raimondi, F.G. Behm, C.H. Pui, J.R. Downing, D.G. Gilliland, et al. 2002. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 1:75–87. 33. Yeoh, E.J., M.E. Ross, S.A. Shurtleff, W.K. Williams, D. Patel, R. Mahfouz, F.G. Behm, S.C. Raimondi, M.V. Relling, A. Patel, et al. 2002. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell. 1:133–143. 34. von Boehmer, H., and H.J. Fehling. 1997. Structure and function of the pre-T cell receptor. Annu. Rev. Immunol. 15:433–452. 35. Bellavia, D., A.F. Campese, S. Checquolo, A. Balestri, A. Biondi, G. Cazzaniga, U. Lendahl, H.J. Fehling, A.C. Hayday, L. Frati, et al. 2002. Combined expression of pTalpha and Notch3 in T cell leukemia identi- fies the requirement of preTCR for leukemogenesis. Proc. Natl. Acad. Sci. USA. 99:3788–3793. 36. Campese, A.F., A.I. Garbe, A.F. Zhang, F. Grassi, I. Screpanti, and H. von Boehmer. 2006. Notch1-dependent lymphomagenesis is assisted by but does not essentially require pre-TCR signaling. Blood. 108:305–310. 37. Ciofani, M., and J.C. Zuniga-Pflucker. 2005. Notch promotes survival of pre-T cells at the beta-selection checkpoint by regulating cellular metabolism. Nat. Immunol. 6:881–888. 38. Zhu, C., K.D. Mills, D.O. Ferguson, C. Lee, J. Manis, J. Fleming, Y. Gao, C.C. Morton, and F.W. Alt. 2002. Unrepaired DNA breaks in p53-deficient cells lead to oncogenic gene amplification subsequent to translocations. Cell. 109:811–821. 39. Maillard, I., A.P. Weng, A.C. Carpenter, C.G. Rodriguez, H. Sai, L. Xu, D.Allman, J.C.Aster, and W.S. Pear. 2004. Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood. 104:1696–1702. 40. Aifantis, I., C. Borowski, F. Gounari, H.D. Lacorazza, J. Nikolich-Zugich, and H. von Boehmer. 2002. A critical role for the cytoplasmic tail of pTalpha in T lymphocyte development. Nat. Immunol. 3:483–488. 2861